Redefining Real-World Evidence: John Snow Labs Introduces First FDA-Ready Patient Journey Platform

Redefining Real-World Evidence: John Snow Labs Introduces First FDA-Ready Patient Journey Platform

LEWES, Del., Jan. 21, 2026 (GLOBE NEWSWIRE) -- John Snow Labs, a healthcare AI company, today announced that its Patient Journey Intelligence (PJI) platform is the first secondary-use data platform designed specifically to meet the requirements of the U.S. Food and Drug Administration's (FDA) newly finalized guidance on the use of real-world evidence (RWE) to support regulatory decision-making for medical devices. The December 2025 final FDA gui…